| | Symbol | Market Cap | | AbbVie Inc. | ABBV | $101,981M | | Accretive Health Inc. | ACHI | $590M | | Acorda Therapeutics, Inc. | ACOR | $1,606M | | Actelion Pharmaceuticals Ltd. | ATLN VX | $13,645M | | Adeptus Health Inc | ADPT | $771M | | Advisory Board | ABCO | $1,657M | | Aetna Inc. | AET | $29,740M | | Agilent Technologies | A | $12,900M | | Albany Molecular Research Inc. | AMRI | $483M | | Alexion | ALXN | $36,468M | | Alkermes Plc | ALKS | $7,812M | | Allscripts Healthcare Solutions | MDRX | $2,243M | | Alnylam Pharmaceuticals Inc | ALNY | $7,227M | | AmerisourceBergen Corp. | ABC | $19,932M | | AngioDynamics Inc. | ANGO | $663M | | Anthem, Inc. | ANTM | $35,581M | | Aratana Therapeutics, Inc | PETX | $423M | | Arrowhead Research Corporation | ARWR | $341M | | Astellas Pharma Inc. | 4503 JP | $32,229M | | athenahealth Inc. | ATHN | $4,956M | | AtriCure Inc. | ATRC | $538M | | Avalanche Biotechnologies Inc. | AAVL | $1,029M | | Banyan Biomarkers, Inc. | Private | | | Baxter International | BAX | $38,887M | | Becton Dickinson & Co. | BDX | $28,013M | | BioCryst Pharmaceuticals Inc. | BCRX | $769M | | Boston Scientific Corp. | BSX | $17,244M | | Brookdale Senior Living | BKD | $6,307M | | Bruker Corporation | BRKR | $3,071M | | Cardinal Health | CAH | $26,593M | | Cardiovascular Systems Inc. | CSII | $933M | | Catamaran Corp. | CTRX | $10,187M | | Celgene Corp. | CELG | $89,518M | | Cempra Inc. | CEMP | $1,079M | | Centene Corporation | CNC | $5,667M | | Cerner Corp. | CERN | $21,960M | | Cerulean Pharma Inc. | CERU | $152M | | Charles River Laboratories | CRL | $2,940M | | Chemed Corp. | CHE | $1,785M | | Chimerix, Inc. | CMRX | $1,389M | | CIGNA Corp. | CI | $26,610M | | Civitas Solutions, Inc. | CIVI | $599M | | Cocrystal Pharma Inc. | COCP | $55M | | Community Health Systems | CYH | $5,248M | | CompanionDx | Private | | | Concert Pharmaceuticals, Inc. | CNCE | $255M | | CR Bard Inc. | BCR | $13,206M | | CVS Health Corp. | CVS | $111,747M | | Cyberonics, Inc. | CYBX | $1,524M | | DBV Technologies SA | DBV | $826M | | DexCom Inc. | DXCM | $4,055M | | DiaSorin SpA | DIA IM | $20,070M | | Direct Flow Medical | Private | | | Eli Lilly and Company | LLY | $74,967M | | Enanta Pharmaceuticals Inc. | ENTA | $800M | | Endo International plc | ENDP | $14,890M | | Envision Healthcare | EVHC | $6,815M | | Esperion Therapeutics Inc. | ESPR | $712M | | ExamWorks Group, Inc. | EXAM | $1,555M | | Express Scripts | ESRX | $57,150M | | Five Prime Therapeutics | FPRX | $625M | | Flamel Technologies SA | FLML | $658M | | Flex Pharma Inc. | FLKS | $252M | | Foamix Pharmaceuticals Inc. | FOMX | $175M | | Genesis HealthCare, Inc. | GEN | $333M | | Gilead Sciences Inc. | GILD | $155,543M | | GlaxoSmithKline | GSK LN | $108,570M | | H Lundbeck A/S | LUN DC | $25,216M | | Halozyme Therapeutics, Inc. | HALO | $973M | | HCA Holdings Inc. | HCA | $31,624M | | HCP, Inc. | HCP | $20,828M | | Health Care REIT | HCN | $24,988M | | HeartWare International Inc. | HTWR | $126M | | Henry Schein Inc | HSIC | $11,123M | | HIMSS Analytics | Private | | | Hologic Inc. | HOLX | $8,226M | | Humana Inc | HUM | $20,818M | | Immune Design Corp. | IMDZ | $391M | | Imprivata Inc. | IMPR | $338M | | Incyte Corp. | INCY | $14,034M | | Integra Lifesciences Corporation | IART | $1,562M | | Ironwood Pharmaceuticals Inc. | IRWD | $1,943M | | Jazz Pharmaceuticals | JAZZ | $10,560M | | Juno Therapeutics Inc. | JUNO | $3,842M | | K2M Group Holdings Inc. | KTWO | $738M | | Karyopharm Therapeutics Inc. | KPTI | $995M | | Kindred Healthcare | KND | $1,287M | | Kite Pharma Inc. | KITE | $2,882M | | Laboratory Corp. of America Hldgs. | LH | $9,752M | | Lombard Medical Inc. | EVAR | $87M | | Magellan Health, Inc. | MGLN | $1,683M | | Mallinckrodt | MNK | $10,018M | | MAXIMUS, Inc. | MMS | $3,314M | | Mazor Robotics Ltd. | MZOR | $314M | | MedAssets, Inc. | MDAS | $1,234M | | Medivation, Inc. | MDVN | $8,079M | | Medtronic Inc. | MDT | $71,383M | | Merck & Co. | MRK | $179,177M | | Merrimack Pharmaceuticals Inc. | MACK | $1,058M | | Mylan Inc. | MYL | $19,739M | | Myriad Genetics Inc. | MYGN | $2,437M | | Neuralstem Inc. | CUR | $327M | | Neurocrine Biosciences, Inc | NBIX | $2,325M | | Novadaq Technologies Inc. | NVDQ | $890M | | Novo Nordisk | NOVOB DC | $114,388M | | NuVasive Inc. | NUVA | $2,135M | | NxStage Medical Inc. | NXTM | $1,044M | | Omnicare, Inc. | OCR | $6,859M | | Ophthotech Corp. | OPHT | $1,569M | | Organovo Holdings Inc. | ONVO | $467M | | Owens & Minor, Inc. | OMI | $2,098M | | Pacira Pharmaceuticals Inc. | PCRX | $3,177M | | PAREXEL International | PRXL | $2,978M | | Patterson Companies Inc | PDCO | $4,868M | | PerkinElmer Inc. | PKI | $4,677M | | Perrigo Co PLC | PRGO | $21,811M | | Pfenex Inc. | PFNX | $135M | | Pfizer Inc. | PFE | $196,896M | | Phibro Animal Health Corp. | PAHC | $1,092M | | PTC Therapeutics Inc. | PTCT | $1,695M | | Qiagen NV | QGEN | $5,219M | | Quest Diagnostics Inc. | DGX | $10,046M | | Quidel Corp. | QDEL | $971M | | Quintiles Transnational | Q | $7,335M | | Receptos Inc. | RCPT | $3,322M | | Regeneron Pharmaceuticals, Inc | REGN | $40,974M | | ReWalk Robotics Ltd. | RWLK | $254M | | Sabra Health Care REIT, Inc. | SBRA | $1,815M | | Sanofi | SASY PA | $121,143M | | Sarepta Therapeutics Inc. | SRPT | $508M | | Seattle Genetics Inc. | SGEN | $3,891M | | Shire PLC | SHP LN | $43,596M | | St. Jude Medical Inc. | STJ | $18,965M | | Stealth BioTherapeutics | Private | | | Syneron Medical Ltd. | ELOS | $339M | | Team Health Holdings, Inc. | TMH | $3,874M | | Tekmira Pharmaceuticals Corporation | Private | | | Teleflex Incorporated | TFX | $4,756M | | Tenet Healthcare Corp. | THC | $4,939M | | TESARO Inc. | TSRO | $1,532M | | Teva Pharmaceutical Industries | TEVA | $56,082M | | TherapeuticsMD Inc. | TXMD | $646M | | Thermo Fisher Scientific Inc | TMO | $49,495M | | Thoratec Corp. | THOR | $1,739M | | TransEnterix Inc. | TRXC | $186M | | Trevena Inc. | TRVN | $212M | | Trupanion, Inc | TRUP | $193M | | UCB SA | UCB BR | $15,540M | | Ultragenyx Pharmaceutical Inc. | RARE | $1,835M | | UnitedHealth Group | UNH | $98,926M | | Universal American Corp. | UAM | $723M | | Universal Health Services | UHS | $10,556M | | Vectura | VEC LN | $831M | | Versartis Inc. | VSAR | $537M | | Vertex Pharmaceuticals Inc | VRTX | $27,150M | | VWR Corp. | VWR | $3,205M | | WellCare Health Plans Inc. | WCG | $3,383M | | West Pharmaceutical Services, Inc. | WST | $3,716M | | Wright Medical Group, Inc. | WMGI | $1,305M | | WuXi PharmaTech Inc. | WX | $2,739M | | Zeltiq Aesthetics Inc. | ZLTQ | $1,101M | | Zoetis Inc. | ZTS | $21,717M |
|
